BTIG Raises Denali Therapeutics PT to $32 from $32 on Buy Rating

Friday, Feb 6, 2026 5:33 am ET1min read
DNLI--

BTIG Raises Denali Therapeutics PT to $32 from $32 on Buy Rating

BTIG Raises Denali Therapeutics PT to $32 from $32 on Buy Rating

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet